| Document ID | Title | Clinical/
Administrative | Distribution Level |
| NEW (6) |
| 302.01 | First Service Contact | Clinical | Directly Operated and Contract |
| 306.31 | Medication Safety Committee | Clinical | Directly Operated |
| 306.32 | Interfacility Transfer of Medications | Clinical | Directly Operated |
| 306.33 | Buprenorphine Extended-Release (SUBLOCADE) Injection | Clinical | Directly Operated |
| 306.35 | Naloxone (NARCAN) Distribution Program | Clinical | Directly Operated |
| 306.36 | Distribution of Fentanyl Test Strips | Clinical | Directly Operated |
| REVISED (8) |
| 303.07 | Reporting Named or Alleged Licensees to Licensing Boards | Clinical | Directly Operated |
| 306.01 | Medication Delivery | Clinical | Directly Operated |
| 306.03-P | Procedures - Point-of-Care Blood Glucose Testing | Clinical | Directly Operated |
| 306.08-P | Procedures - Administration of Intranasal Naloxone | Clinical | Directly Operated |
| 306.11-P | Procedures - CareStart COVID-19 Antigen Point-of-Care Test | Clinical | Directly Operated |
| 306.11-P | Procedures - Flowflex COVID-19 Antigen Home Test | Clinical | Directly Operated |
| 306.26-P | Procedures - Point-of-Care Pregnancy Testing | Clinical | Directly Operated |
| 306.28-P | Procedures - Urine Drug Screen | Clinical | Directly Operated |
| UPDATED PARAMETERS (1) |
| MED-08 | Psychotropic Medication in Children and Adolescents | Clinical | Directly Operated |
| DELETED (0) |
